Before we’ve even met

Should you build something around the thing that got you better?

Maybe. It comes down to one answer you can get in a week, and to which version of this you actually want.

We haven’t met yet, so everything here is our best guess about your world, not the truth handed down. We wrote it up early so you can tell us where we’re wrong before we meet. Read it, push back, keep what’s useful, toss the rest.

How this works

As you read, you can nod along, fix what’s off, or cross out what doesn’t fit. Whatever rings true collects on one page you can keep, and bring to a conversation whenever you want.

Why the order matters

The order’s on your side

This isn’t one big yes or no. It’s a handful of smaller questions, lined up so the most make-or-break one comes first. If it’s no, we find out in a week, not after you’ve built the whole thing. Everything else can wait until that one’s a yes.

When you’re ready, and not before

Give us an hour whenever you want. We’ll work out which version you’re actually after, and where our read is off. Then you make two phone calls. None of it costs more than a week.

Listen→Frame→Envision→Explore→Decide→A page to keep
A Dark Horse Works point of view

The Door Before the Room

What happens when an innovator becomes his own best evidence.

By Dark Horse Works/For Casey Jennings/7 min read

#{{ sec.heading }}

{{ p.text }}

{{ p.text }}

{{ p.text }}
A Dark Horse Works point of view
Listen

What we understand so far

None of this came from you. We haven’t talked yet, so we sorted it by how sure we are:

  • Relayed we heard it secondhand.
  • Structural it’s just true of your world.
  • Inferred we’re guessing, and that’s where to push hardest.
{{ listenProgress }}
reviewed

The whole point is for you to fix it. Keep what holds, fix what’s off, cut what’s wrong. We’d rather say too little than put words in your mouth.

How we know it
{{ listenStepLabel }}
Said on a call

Nothing here yet.

This fills in when we talk. Everything else here is our outside read. Your own words are the one thing we’re missing, and they’re exactly what a first conversation is for.
{{ listenCurrent.num }} {{ listenCurrent.layer }} · {{ listenCurrent.layerNote }}

{{ listenCurrent.headline }}

{{ listenCurrent.body }}

{{ listenCurrent.linkLabel }} ↗

{{ listenCurrent.detail }}
What did we miss
Frame

We think there’s a harder, more useful question than “should you add peptides, and what should you build around them?”

The question

How do you turn a personal conviction into an offer people actually want, that you can defend, and that stands apart?

The trick is not letting your excitement outrun what you can source, prove, and stand behind. Everything else comes down to that push and pull between conviction and caution.

The answer

Sell the outcome, not the molecule.

What the pet parent remembers is the afternoon the dog put weight on the leg it wouldn’t touch. That is what they pay for. The molecule stays backstage, doing its quiet work, named only when it matters.

The frame we’d start from

Preloaded, but yours to edit. It commits to nothing. It is just the sentence the rest would start from.

The one thing to get right

Own one kind of recovery so completely that you’re the obvious choice for it.

Keep the peptides in the back room: a careful, optional tool behind that recovery, never the thing you sell. Get that one thing right and the rest, pricing, marketing, careful sourcing, growth, falls into place behind it.

But the gate comes first. None of this is worth building unless you can get a clean, patient-specific supply and stand on solid legal ground. That’s the price of entry, not the plan, and two calls will tell you. Your edge is real: a vet who was healed by this, who can wrap it in real rehab, and who refuses to oversell it. Credible and willing, both at once. Almost no one else can stand there.

Why this isn’t cooling the conviction

The answer is not to cool the conviction. That would throw away the very thing that lets you champion this when no one else will. Hold it with steady hands, and let it reach only as far as the evidence will bear weight.

Six other ways to name it, ranked

Each is a different way to define the core challenge, and each points to a different strategy. Not all are winnable. Re-rank by which feels most true, by dragging a row or using the arrows. Our order is a starting point, not a verdict.

{{ p.rank }}
drag

{{ p.text }}

{{ p.read }}
Our verdict
{{ p.verdict }}
The problems underneath, our read
{{ p.code }}
{{ p.label }}
{{ p.text }}
Envision

Choose the destination

The crux is the same in all three. What changes is where the weight sits, and that changes what arriving feels like. Pick the one you’d actually want to live inside, including the choice not to build.

{{ destinationNote }}

What it looks like when you get there

Choose the elements that describe where this should go. Edit any that are close but not right.

{{ e.tagLabel }}

{{ e.title }}

{{ e.body }}
The trade-offs to choose
{{ t.pair }}
{{ t.q }}

If this worked beautifully but you could only ever help a dozen dogs a year, would it still be worth doing?

What “there” is not

Part of choosing a destination is refusing the ones your enthusiasm will reach for. These are off the table. Edit them, or add your own.

{{ na.text }}
Passages you marked on the article

{{ fp.text }}
The choice

One has to lead now, because it decides what comes next.

Before we solve anything, there is a map worth arguing with: where the defensible place to start actually is.
Explore

Where the defensible wedge actually is

Twelve candidate use cases, scored on how much pet parents want them against how safely a Phoenix clinic can stand behind them. Bubble size is how often the case walks in the door. The shaded corner is the beachhead. Only one case lands there, and it gets there by being framed as rehab, not peptides. A map to argue with, not a recommendation to accept.

Register
Strategic tier Toggle a tier on or off. Only the beachhead is worth going first.
{{ plotSvg }}
○ Musculoskeletal recovery & repair◇ Other body systems
How to read this

The attractive cases cluster on the right, on demand, but slide down on defensibility, dragged there almost entirely by sourcing. The winning point isn’t a new condition to treat. It’s the same post-surgical case, reframed so peptides are optional, which is what pushes it over the line on safety. Scores are estimates with stated confidence, not measured values.

{{ activeBubble.tierLabel }}

{{ activeBubble.name }}

{{ activeBubble.indication }}
Attractiveness
{{ activeBubble.attract }}
Defensibility
{{ activeBubble.defend }}
{{ sc.label }} {{ sc.val }}

{{ activeBubble.why }}

{{ activeBubble.peptides }}
Read a case

Hover or tap any case on the map to see what it is, its seven scores, and why it lands where it does. Bubble size is how often the case walks in the door.
Where the map points

A post-surgical rehab bundle, peptides optional and consent-heavy. Sell the recovery outcome; keep the molecule backstage. The framing is what lifts it over the defensibility line.

It is the same TPLO recovery case the attractive cluster is built on, reframed as rehab. Offered as where the map points, to argue with, not to accept.
Decide

The choice, and the gate in front of it

The decision is yours to make. This just lays out the shape of it, the order, and how you’d know, so you can argue with it before you have to stand inside it.

The decision, in one line

Will you build a canine-recovery offer, with peptides kept as a careful, optional tool, and if so, which version, and only once you’ve proven you can get them cleanly?

That’s not one decision. It’s a few, in an order that protects you: the cheapest, most make-or-break question comes first, so a no costs you a week, not a launch.

Gate 0

Can it be sourced and defended?

Decide this first, cheaply. Before destination, before pricing, before a single case: two calls, a compounding pharmacy and Arizona counsel, using the scripts already prepared. Any single red closes the gate, regardless of how good the clinical or commercial story is.

Green · proceed

A licensed pharmacy will prepare a patient-specific, USP-grade preparation you can stand behind, and counsel sees a defensible path under a valid Arizona VCPR.

Red · stop here

The only supply is research-grade or bulk, no clean legal basis exists, the board has disciplined similar use, or your carrier would exclude it. This isn’t a failure. It’s the gate doing its job.

Choice 1

Which destination leads?

Only if the gate is green. Same crux either way, the weight just sits differently. Which one leads changes the most about what comes next, and it’s the first thing to settle in a working hour.

The commitment, the smallest honest bet

If A or B. Not a menu, not a clinic. A small pilot you can learn from and defend.

{{ c.k }} {{ c.v }}
How you’ll know, pre-committed criteria

Decide these before you start, because enthusiasm won’t set them for you later. Edit them now, while judgment holds the pen.

Go / continue
Kill
What we are not deciding now

Not pricing, not marketing, not the peptide formulary, not expansion. Not longevity, performance, or a broad peptide line. This decision is only: clear the gate, choose a destination, and if you proceed, commit to one small reversible bet.

One working hour to set the aim and check where we’re wrong. Then the two calls. None of it costs more than a week.
Your next steps

Two calls before anything else

A peptide offer only holds up if you can get it cleanly. Two calls tell you whether it can. Everything after, pricing, packaging, how you stack up against Legacy, is noise until you know.

The two calls at a glance

Make Call 1 first: if you can’t get it cleanly, the legal questions are moot. Treat both as a gate, not a survey. You’re finding out whether a clean path exists, not fishing for reassurance that it might.

How to run both calls

Lead with the fact pattern, not your enthusiasm. The more you signal how badly you want a yes, the more likely you are to be told what you want to hear. State the constraints plainly and let them tell you what they won’t do.

The fact pattern, say this near the top of both calls

“{{ factPattern }}”

Call 1

Compounding pharmacy

The one that decides everything: can you get these peptides clean and legal? Make this call first.

{{ pharmacyWho }}

{{ g.label }}
Reading the answers
Green

{{ pharmacyReading.green }}

Yellow

{{ pharmacyReading.yellow }}

Red

{{ pharmacyReading.red }}

Call 2

Arizona counsel

Only worth having if Call 1 came back clean: if you can get it, can you prescribe and defend it?

{{ counselWho }}

Reading the answers
Green

{{ counselReading.green }}

Yellow

{{ counselReading.yellow }}

Red

{{ counselReading.red }}

Who to actually call

{{ whoToCall }}

{{ disclaimer }}

What to do this week, while it’s alive
A page to keep

Your read, gathered

This gathers only what you affirmed or wrote across the pages, so you can bring it into a working hour. It is a keepsake of the thinking, not a proposal and not an agreement.

Dark Horse Works · for Casey Jennings

The door before the room

{{ sessionDate }}

As you move through the pages, what you affirm will gather here.
The identity on offer, if you want it

{{ identityLine }}

The frame you’d start from

{{ memoFrame }}

The destination you’re aiming at

{{ memoDestination.key }} · {{ memoDestination.label }}. {{ memoDestination.vision }}

The gate you’ll clear first

Two calls before anything else, a compounding pharmacy and Arizona counsel. A no closes the gate. Green proceeds to the choice.
What we understand that held
  • {{ m.headline }}. {{ m.body }} · {{ m.layer }}
    •
How you rank the core challenge
  1. {{ m.text }} · {{ m.verdict }}
    2.
The outcomes you chose
  • {{ m.title }}. {{ m.body }}
    •
Your criteria, set in advance

Go. {{ goCriteria }}

Kill. {{ killCriteria }}

What this is not
  • {{ n.text }}
    •
What you’ll do this week
  • {{ w.text }}
    •
Passages you marked

{{ fp.text }}
Dark Horse Works
If the thinking is useful, let’s talk.
No commitment. A working hour, whenever it’s useful to have one. {{ contactLink }}
Start a conversation